Evidence map›Paper›PMID 28134930›Full record

ArticleNature structural & molecular biology2017

Xist-dependent imprinted X inactivation and the early developmental consequences of its failure.

Maud Borensztein, Laurène Syx, Katia Ancelin, Patricia Diabangouaya, Christel Picard, Tao Liu, Jun-Bin Liang, Ivaylo Vassilev, Rafael Galupa, Nicolas Servant and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 2 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 2 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Maud BorenszteinInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.ORCID 0000-0002-4378-5018
Laurène SyxInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.
Katia AncelinInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.ORCID 0000-0002-2117-9754
Patricia DiabangouayaInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.
Christel PicardInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.
Tao LiuAnnoroad Gene Technology Co., Ltd, Beijing, China.
Jun-Bin LiangAnnoroad Gene Technology Co., Ltd, Beijing, China.
Ivaylo VassilevInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.
Rafael GalupaInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.ORCID 0000-0001-7319-043X
Nicolas ServantInstitut Curie, PSL Research University, Mines Paris Tech, Bioinformatics and Computational Systems Biology of Cancer, INSERM U900, F-75005, Paris, France.
Emmanuel BarillotInstitut Curie, PSL Research University, Mines Paris Tech, Bioinformatics and Computational Systems Biology of Cancer, INSERM U900, F-75005, Paris, France.ORCID 0000-0003-2724-2002
Azim SuraniWellcome Trust Cancer Research UK Gurdon Institute, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Chong-Jian ChenAnnoroad Gene Technology Co., Ltd, Beijing, China.
Edith HeardInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRUniversity of Cambridge · GB

Funding

European Research Council 250367
6 · The paper itself

Abstract

The long noncoding RNA Xist is expressed from only the paternal X chromosome in mouse preimplantation female embryos and mediates transcriptional silencing of that chromosome. In females, absence of Xist leads to postimplantation lethality. Here, through single-cell RNA sequencing of early preimplantation mouse embryos, we found that the initiation of imprinted X-chromosome inactivation absolutely requires Xist. Lack of paternal Xist leads to genome-wide transcriptional misregulation in the early blastocyst and to failure to activate the extraembryonic pathway that is essential for postimplantation development. We also demonstrate that the expression dynamics of X-linked genes depends on the strain and parent of origin as well as on the location along the X chromosome, particularly at the first 'entry' sites of Xist. This study demonstrates that dosage-compensation failure has an effect as early as the blastocyst stage and reveals genetic and epigenetic contributions to orchestrating transcriptional silencing of the X chromosome during early embryogenesis.

Indexed as

Genomic ImprintingAllelesAnimalsBlastocystCell DifferentiationDosage Compensation, GeneticEmbryo ImplantationEmbryo, MammalianEmbryonic DevelopmentFemaleGene Expression Regulation, DevelopmentalGene Knockout TechniquesGene SilencingGenes, X-LinkedKineticsMaleRNA, Long NoncodingXIST non-coding RNA

Identifiers

PMID28134930
PMCPMC5337400
OpenAlexW2580528096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.